Session date:
11/07/2018 - 12:00pm to 1:00pm
Nanette K. Wenger, M.D.
Professor of Medicine, Cardiology
Emory University School of Medicine
Consultant, Emory Heart and Vasular Center
Founding Consultant, Emory Women's Heart Center
Locations:
- Geffen Auditorium (Live)
- Broadcast to SMH Alfred M-459 and BA 4-316/BA 4-516
- Mayo Clinic Health System in Waycross (Video Conference)
Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first come, first serve basis
Learning Objectives:
- Recognize the past, present, and future of cardiovascular disease in women
- Acknowledge the advances regarding cardiovascular disease in women in the past decade
Financial Disclosures:
Grant/Research Support - Gilead Sciences, NHLBI, Pfizer, Society for Women's Heart Research
Consultant - Amgen, AstraZeneca, Gilead Sciences, Janssen Pharmaceuticals
Off Label/Investigational uses:
None
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
Presenter:
Nanette K. Wenger, M.D.
Where did the idea for the course originate?:
Minnesota
Where did the idea for the course originate?:
Minnesota

Facebook
X
LinkedIn
Forward